A phase I study of intravenous and oral rucaparib in combination with chemotherapy in patients with advanced solid tumours
<p>Background: This study evaluated safety, pharmacokinetics, and clinical activity of intravenous and oral rucaparib, a poly (ADP-ribose) polymerase inhibitor, combined with chemotherapy in patients with advanced solid tumours.</p> <p>Methods: Initially, patients received escalati...
| Main Authors: | , , , , , , , , , , |
|---|---|
| 格式: | Journal article |
| 出版: |
Cancer Research UK
2017
|